Company intelligence
Idorsia Pharmaceuticals Ltd
About Idorsia Pharmaceuticals Ltd
The purpose of Idorsia is to discover, develop, and commercialize innovative medicines to help more patients. We have more ideas, we see more opportunities, and we want to transform the horizon of therapeutic options. In order to achieve this, we will develop Idorsia into a leading biopharmaceutical company, with a strong scientific core. Headquartered in Switzerland – a biotech-hub of Europe – Idorsia is a high-potential biopharmaceutical company, specialized in the discovery, development and commercialization of innovative small molecules, with the aim of transforming the horizon of therapeutic options. See our LinkedIn community guidelines: https://bit.ly/4nAfOZp Idorsia privacy policy: https://www.idorsia.com/legal/privacy-policy
Verified activity
Signals from Idorsia Pharmaceuticals Ltd
4 published signals
People
Idorsia Pharmaceuticals Ltd introduced Amer Joseph as Chief Medical Officer and Head of Global Clinical Development.
Reported by Idorsia Pharmaceuticals Ltd
Presence & Recognition
Idorsia Pharmaceuticals Ltd is releasing a new episode of the Beyond the Ache podcast each week throughout September.
Reported by Gabriel Baertschi
Presence & Recognition
Idorsia Pharmaceuticals Ltd is hosting the Care4Pain2026 initiative on 18-19 September in Berlin to explore emerging science in neuropathic pain.
Reported by Gabriel Baertschi
Presence & Recognition
Idorsia Pharmaceuticals Ltd participated in the 2026 ESC Congress.
Reported by Idorsia Pharmaceuticals Ltd